Lenacapavir HIV prevention could significantly shorten the time South Africa needs to bring HIV transmission under control. However, modelling suggests the country would need millions of people to receive the long-acting injection each year to realise its full potential. Clinical trials found that lenacapavir provided almost complete protection against HIV infection. The injectable prevention option could also address a persistent…